Genetic competence in Bacillus subtilis is the ability to process and take up exogenous DNA into the cell. 1) Competence development is regulated by both cell density and nutrient limitation signals. 2, 3) ComA, the response regulator of the ComP-ComA two-component system, is activated by cell-density signals through its phosphorylation. 3, 4) Phosphorylated ComA activates transcription of the srfA operon, which encodes enzymes for the synthesis of surfactin and the competence regulator ComS, located within and out-of-frame with srfAB. There are two known extracellular factors, ComX and PhrC, by which ComA is activated. 4) When B. subtilis cells reach stationary phase, the concentration of ComX becomes high enough to interact with the ComP kinase. On the other hand, the PhrC pentapeptide is imported into the cell by oligopeptide permease (Opp), 4) and probably inhibits the activity of RapC phosphatase, the target of which is phosphorylated ComA. Opp is an ABC transporter composed ofˆve subunits. One subunit, OppA, is a lipoprotein and works as a substrate-binding protein for the transporter. Various lipoproteins have been shown to function as substrate-binding proteins for transporters. 5) In eubacteria the process of lipid modiˆcation is well conserved. The diacylglyceryl transferase encoded by lgt transfers a diacylglyceryl moiety to the cysteine residue downstream from a target signal peptide, 6, 7) followed by the removal of the signal peptide from the lipid-modiˆed substrate by signal peptidase II. 8) ComK is a master regulator of competence development, 9) which is necessary for transcription of the four late com operons encoding the apparatuses for processing and taking up DNA (comC, comE, comF, and comG ). When competence development is repressed, ComK is part of a ternary complex with MecA and ClpC, which belongs to a large family of regulatory subunits of ATP-dependent proteases. 10, 11) The catalytic subunit of the protease, ClpP, associates with this complex, and the resultant ClpCP protease is thought to degrade ComK. 12) In the complex ComK is inactive and cannot bind to its target DNA. Once ComS is produced in the cell by virtue of extracellular regulation through ComP-ComA, it binds to MecA and releases ComK from the complex, [11] [12] [13] resulting in the binding of ComK to AT-rich ComK boxes in the regulatory regions of these operons. 14) Recently we have found a positive regulatory factor for comK transcription, med.
15) The med and downstream comZ genes constitute an operon involved in competence development. 15, 16) In this paper we present evidence that Med is located at the cell surface.
We reported that expression of comK-lacZ was reduced in the med mutant. 15) To conˆrm the observation at the protein level, polyclonal antibody was raised in rabbits against a synthetic peptide derived from a C-terminal region of ComK (NH 2 -KMIYD-FILRELGE-COOH). Synthesis of the peptide and immunization were done by Sawady Technology Co. (Tokyo, Japan). This antibody was used to measure ComK in the med mutant grown in competence medium. By using this antibody, an immuno-reactive band with a molecular mass of ComK was detected in med + cells, but not in comK-deˆcient cells, indicating that the detected band is indeed ComK (Fig. 1) . In the med mutant the amount of ComK was greatly OGM100 (WT), OGM101 (med ), and OGM104 (comK ) cells were grown in 100 ml of modiˆed competence (MC) medium 15) and harvested at T0 and T2 relative to the end of the vegetative growth (T0). After cell disruption by a French press and measurement of the protein concentration by a Bio-Rad Protein Assay Kit, samples were mixed with SDS-PAGE sample buŠer and put onto a gel. Western analysis was done using a PVDF membrane (Boehiringer Manheim) and BM Chemiluminescence Western Blotting Kit (Rabbit W Mouse) (Boehiringer Manheim Co.).
reduced, which is consistent with the former observation obtained by comK-lacZ fusion experiments. 15) Med has a hydrophobic stretch composed of 14 amino acids followed by a putative lipo-modiˆcation signal, LSGC, at its N-terminus. 15) This feature strongly suggested that Med may be subject to signal peptide processing and lipid modiˆcation. To test this possibility, we constructed a fusion between the N-terminal half of Med and the E. coli alkaline phosphatase (AP) lacking its signal peptide, essentially as described by Dartois et al. 6) It has been known that AP is active only when translocated across the membrane, 17) and thus AP fusion is used for measurement of protein localization.
A plasmid pMed-PhoA1 used for such experiments carried an in-frame fusion between an N-terminal region of med containing the putative signal peptide followed by the lipo-modiˆcation signal and phoA without its signal peptide. It was constructed in three steps. A PCR product ampliˆed by using Med-AP-U (5?-GTCGAATTCAAGCTTCCTCAAAAGAAGA-AGCAAAA-3?) and Med-AP-D (5?-GTCGATAT-CAGGAAAGAGCATGCCGA-3?) as primers and the total DNA of CU741 15) as a template was digested with PvuII and EcoRI and cloned into pJV211 6) treated with EcoRV and EcoRI. The plasmid thus constructed was digested with HindIII, and the fragment containing med-phoA was cut out from an agarose gel and cloned into the HindIII-digested pMA5.
18) The resultant plasmid was cut with SacI and self-ligated to generate pMed-PhoA1. To introduce mutations causing a change of cysteine to proline or alanine into pMA5 carrying the med-phoA fusion, a Quick-change site-directed mutagenesis kit (Stratagene, CA, U.S.A.) and oligonucleotide pairs, Med-CP-U (5?-ATTGAGTGGACCTGGACAAA-CT-3?) and Med-CP-D (5?-AGTTTGTCCAGGT-CCACTCAAT-3?), and, Med-CA-U (5?-ATTGAG-TGGAGCTGGACAAACT-3?) and Med-CA-D (5?-AGTTTGTCCAGCTCCACTCAAT-3?) were used, respectively. The resultant pMA5 derivatives were put through the same procedures used for construction of pMed-phoA1. All the PCR-derived regions of the cloned DNA were sequenced using a 377 DNA Sequencer and Dye Terminator Cycle Sequencing Kit (Perkin Elmer). Oligonucleotides were commercially prepared by Espec Oligo Service (Ibaraki, Japan).
The AP assay was done as follows. One ml of the culture was taken at hourly intervals. After centrifugation the pellets were washed by the same volume of TE buŠer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) and resuspended in 1 ml TE buŠer. The suspension thus obtained was designated as an intact-cell fraction. Next, to obtain a protoplast fraction cells were centrifuged, resuspended in the same volume of TE buŠer containing 20 mM MgCl2 and 20z sucrose with lysozyme (1 mg W ml; Sigma Co.) and incubated at 379 C for 30 min, followed by a wash with the same volume of the TE buŠer. The protoplasts were directly resuspended with the buŠer for the AP assay. Detection of AP activities in intact cells, protoplasts, and culture supernatant was done as described in Dartois et al. Weˆrst examined the AP activity in the intact cell fraction of the wild-type Med-AP fusion. Activity higher than the background level was detected although the overall activity was very low for an unknown reason (data not shown). Thus, we next did the AP assay using the protoplast fraction. As shown in Fig. 2A , an AP activity from the Med-AP fusion was observed, indicating that the fusion was speciˆ-cally localized at the outer region of the cell membrane. In addition, considerable amounts of the AP activity were also detected in the culture supernatant ( Fig. 2A) . This is consistent with the previous observation that lipoprotein of Gram-positive bacteria can be released from the cell surface into the medium. 7) In a lgt disruptant, the activity of the fusion was barely detected in the protoplast fraction but considerably in the culture supernatant ( Fig. 2A) , suggesting that the fusion could not be e‹ciently localized at the cell surface in the lgt strain. It is speculated that the attachment of the diacylglyceryl moiety to the cysteine residue of the Med-AP fusion and removal of the signal peptide would not occur in the lgt strain as in the case of a lipoprotein, PrsA, 7) resulting in diŠusion of the fusion into the medium. However, we do not know the reason for this phenomenon. Next, we introduced mutations that replace the cysteine residue within the lipo-modiˆca- CU741 (trpC2 leuC7) 15) and OMM43 (trpC2 leuC7 med ) 15) were grown in MC medium 15) and 250 ml of the sample was taken at T0. S, PS, M, and C indicate the culture supernatant, protoplast supernatant, membrane and cytoplasmic fractions, respectively. The protoplast supernatant fraction contained both the supernatant and wash fractions obtained during the protoplast formation procedure for the AP assay. Protoplasts were disrupted by three cycles of freezing and thawing, and then centrifuged to prepare membrane and cytoplasmic fractions. Equivalent amounts of each fraction were put onto the gel. Procedure for Western analysis is described in legends to Fig. 1. tion signal with alanine or proline and examined the eŠects on surface localization of the fusion, since the cysteine residue is known to play a critical role in lipo-modiˆcation. Figure 2B shows that the mutated AP fusions were no longer found at the protoplast surface and that the amounts of the secreted fusion in the culture supernatant were reduced to about a half compared to that of the wild type fusion (Fig. 2A) . These results indicated that the mutated lipo-modiˆ-cation signal could not e‹ciently direct AP translocation across the membrane. Similar observations have been reported, that the activity of a KapB-AP fusion with the amino acid change of Cys to Pro or Thr in its lipo-modiˆcation signal is greatly reduced. 6) It should be noted that a promoter activity would be the same among the three Med-AP fusions because the DNA fragments carrying mutant Med' were inserted into the same vector. On the basis of these observations it is very likely that Med is subjected to lipid-modiˆcation.
Next, toˆnd the localization of Med directly, cytoplasmic and membrane fractions were prepared (see Legend to Fig. 3 ) and Western blot analysis was done using an antibody raised against a C-terminal peptide of Med (NH 2 -KTYNKTGELPKNE-COOH, Sawady Technology Co). As a result, bands with similar intensity were detected for both fractions (Fig. 3) , so that the correct localization could not be found. This would be attributed to a probable release of the Med protein from the cell membrane in preparing the cytoplasmic and membrane fractions from protoplasts. Therefore, we did Western analysis using the protoplast supernatant fraction. In fact, Med was detected in the protoplast supernatant fraction (Fig. 3) . No immuno-reactive protein was detected in all the fractions of the med strain (only the result in the membrane fraction is shown in Fig. 3) , indicating that the detected band actually originated LivJ. An open box shows identity in the consensus. Alignment to the binding consensus for oligopeptide 21) is also shown.
from the Med protein.
The Western results are consistent with the observation that the Med-AP fusion is localized at the outer surface of the cell membrane. Med was not detected in the culture supernatant ( Fig. 3) , although the experiment using the AP fusion showed a considerable level of activity in the medium fraction ( Fig. 2A) . The apparent discrepancy between the locations of the AP fusion and the Med protein itself may be due to the possibility that the Med protein might have a signal(s) that enables it to be trapped in the cell wall, but the Med-AP fusion might lack such a signal(s). However, this notion is speculative since well-known cell-wall targeting signals such as LPXTG are not detected in the amino acid sequence of Med. 19) From these results we concluded that Med is localized at the outer surface of the cell, probably through lipo-modiˆcation, although direct evidence, such as incorporation of radiolabeled palmitic acid into Med, may be required.
Based on a computer search Med was shown to have a similarity to various substrate-binding lipoproteins. Figure 4 shows an alignment of Med to an aliphatic amino acid-binding protein of E. coli, LivJ. 20) Med has a part of the consensus of the aliphatic amino acids-binding motif. In addition, the region of Med showing sequence similarity to the consensus for aliphatic amino acids could align partially with the consensus for oligopeptide binding. 21) Med might be an orphan substrate-binding protein since the med operon lacks the genes coding for potential subunits to constitute an ABC-transporter. 15) These observations suggest that Med might function as a substrate-binding protein to incorporate some unknown extracellular factor regulating competence development.
